BRPI0408899A - compostos benzo[1,2,5]tiadiazol - Google Patents
compostos benzo[1,2,5]tiadiazolInfo
- Publication number
- BRPI0408899A BRPI0408899A BRPI0408899-9A BRPI0408899A BRPI0408899A BR PI0408899 A BRPI0408899 A BR PI0408899A BR PI0408899 A BRPI0408899 A BR PI0408899A BR PI0408899 A BRPI0408899 A BR PI0408899A
- Authority
- BR
- Brazil
- Prior art keywords
- benzo
- thiadiazole compounds
- compounds
- cck2
- thiadiazole
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/14—Thiadiazoles; Hydrogenated thiadiazoles condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
"COMPOSTOS BENZO¢1,2,5!TIADIAZOL". A presente invenção refere-se a certos compostos amidofenil-sulfanilamino-benzo¢1,2,5!tiadiazol que são moduladores de CCK2 úteis no tratamento de doenças mediadas por CCK2.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US45863803P | 2003-03-28 | 2003-03-28 | |
PCT/US2004/009589 WO2005012275A2 (en) | 2003-03-28 | 2004-03-26 | Benzo [1, 2, 5] thiadiazole compounds as cck2 modulators |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0408899A true BRPI0408899A (pt) | 2006-04-18 |
Family
ID=34115280
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0408899-9A BRPI0408899A (pt) | 2003-03-28 | 2004-03-26 | compostos benzo[1,2,5]tiadiazol |
Country Status (20)
Country | Link |
---|---|
US (2) | US7241759B2 (pt) |
EP (1) | EP1675837A2 (pt) |
JP (1) | JP2006528241A (pt) |
KR (1) | KR20050119666A (pt) |
CN (1) | CN1829704A (pt) |
AU (1) | AU2004261547A1 (pt) |
BR (1) | BRPI0408899A (pt) |
CA (1) | CA2520546A1 (pt) |
CO (1) | CO5700819A2 (pt) |
CR (1) | CR8009A (pt) |
EC (1) | ECSP056057A (pt) |
IS (1) | IS8042A (pt) |
MX (1) | MXPA05010484A (pt) |
NO (1) | NO20055002L (pt) |
NZ (1) | NZ542491A (pt) |
RS (1) | RS20050733A (pt) |
RU (1) | RU2005133206A (pt) |
UA (1) | UA82872C2 (pt) |
WO (1) | WO2005012275A2 (pt) |
ZA (1) | ZA200508732B (pt) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005085188A2 (en) * | 2004-03-02 | 2005-09-15 | Compass Pharmaceuticals Llc | Compounds and methods for anti-tumor therapy |
US7297816B2 (en) | 2004-09-24 | 2007-11-20 | Janssen Pharmaceutica N.V. | Sulfonamide compounds |
US7599588B2 (en) * | 2005-11-22 | 2009-10-06 | Vascular Imaging Corporation | Optical imaging probe connector |
EP1795198A1 (en) * | 2005-12-09 | 2007-06-13 | Hubrecht Laboratorium | Treatment of Barret's esophagus |
WO2008124518A1 (en) * | 2007-04-03 | 2008-10-16 | Janssen Pharmaceutica N.V. | Oxo-dihydroisoindole sulfonamide compounds as modulators of the cck2 receptor |
EP2053052A1 (en) * | 2007-10-23 | 2009-04-29 | Laboratorios del Dr. Esteve S.A. | Process for the preparation of 6-substituted imidazo[2,1-b]thiazole-5-sulfonyl halide |
IN2012DN00471A (pt) | 2009-06-29 | 2015-06-05 | Agios Pharmaceuticals Inc | |
RU2532492C1 (ru) * | 2013-01-28 | 2014-11-10 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Воронежская государственная медицинская академия им. Н.Н. Бурденко" Министерства здравоохранения Российской Федерации | Способ эндоскопического лечения гастродуоденальных язв |
PL3071206T3 (pl) | 2013-11-22 | 2022-01-17 | CL BioSciences LLC | Antagoniści gastryny (eg yf476, netazepid) do leczenia i zapobiegania osteoporozie |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2703995B1 (fr) | 1993-04-16 | 1995-07-21 | Sanofi Elf | 5-acylamino 1,2,4-thiadiazoles, leur preparation et compositions pharmaceutiques en contenant. |
US6239131B1 (en) | 1996-12-10 | 2001-05-29 | Zeria Pharmaceutical Co., Ltd. | 1,5 Benzodiazepine derivatives |
HUP0202142A3 (en) * | 1999-06-24 | 2005-05-30 | Smithkline Beecham Corp Philap | Macrophage scavenger receptor antagonists |
GB0028702D0 (en) | 2000-11-24 | 2001-01-10 | Novartis Ag | Organic compounds |
JP2004529170A (ja) * | 2001-05-07 | 2004-09-24 | スミスクライン・ビーチャム・コーポレイション | スルホンアミド |
ITTO20020674A1 (it) | 2002-07-26 | 2004-01-26 | Rotta Research Lab | Derivati antranilici ad attivita' anticolecistochininica (anti-cck-1), procedimento per la loro preparazione e loro uso farmaceutico |
-
2004
- 2004-03-26 RU RU2005133206/04A patent/RU2005133206A/ru not_active Application Discontinuation
- 2004-03-26 MX MXPA05010484A patent/MXPA05010484A/es unknown
- 2004-03-26 JP JP2006532352A patent/JP2006528241A/ja not_active Withdrawn
- 2004-03-26 AU AU2004261547A patent/AU2004261547A1/en not_active Abandoned
- 2004-03-26 US US10/811,292 patent/US7241759B2/en active Active
- 2004-03-26 RS YUP-2005/0733A patent/RS20050733A/sr unknown
- 2004-03-26 WO PCT/US2004/009589 patent/WO2005012275A2/en active Application Filing
- 2004-03-26 BR BRPI0408899-9A patent/BRPI0408899A/pt not_active IP Right Cessation
- 2004-03-26 EP EP04785868A patent/EP1675837A2/en not_active Withdrawn
- 2004-03-26 CA CA002520546A patent/CA2520546A1/en not_active Abandoned
- 2004-03-26 KR KR1020057018397A patent/KR20050119666A/ko not_active Application Discontinuation
- 2004-03-26 NZ NZ542491A patent/NZ542491A/en unknown
- 2004-03-26 CN CNA2004800144708A patent/CN1829704A/zh active Pending
- 2004-03-26 UA UAA200509353A patent/UA82872C2/uk unknown
-
2005
- 2005-09-23 IS IS8042A patent/IS8042A/is unknown
- 2005-09-28 EC EC2005006057A patent/ECSP056057A/es unknown
- 2005-09-28 CR CR8009A patent/CR8009A/es unknown
- 2005-10-05 CO CO05100979A patent/CO5700819A2/es not_active Application Discontinuation
- 2005-10-27 NO NO20055002A patent/NO20055002L/no not_active Application Discontinuation
- 2005-10-27 ZA ZA200508732A patent/ZA200508732B/en unknown
-
2007
- 2007-07-10 US US11/775,535 patent/US7550492B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
IS8042A (is) | 2005-09-23 |
US7241759B2 (en) | 2007-07-10 |
RS20050733A (en) | 2007-06-04 |
KR20050119666A (ko) | 2005-12-21 |
AU2004261547A1 (en) | 2005-02-10 |
US20070276016A1 (en) | 2007-11-29 |
JP2006528241A (ja) | 2006-12-14 |
ECSP056057A (es) | 2006-01-27 |
NO20055002L (no) | 2005-12-14 |
NO20055002D0 (no) | 2005-10-27 |
MXPA05010484A (es) | 2006-03-10 |
NZ542491A (en) | 2009-04-30 |
CR8009A (es) | 2008-09-10 |
UA82872C2 (en) | 2008-05-26 |
WO2005012275A3 (en) | 2006-05-11 |
RU2005133206A (ru) | 2006-05-10 |
ZA200508732B (en) | 2007-04-25 |
CA2520546A1 (en) | 2005-02-10 |
WO2005012275A2 (en) | 2005-02-10 |
US20040224983A1 (en) | 2004-11-11 |
EP1675837A2 (en) | 2006-07-05 |
CO5700819A2 (es) | 2006-11-30 |
US7550492B2 (en) | 2009-06-23 |
CN1829704A (zh) | 2006-09-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0413449A (pt) | compostos de quinoxalina | |
BRPI0516027A (pt) | compostos de sulfonamida | |
BRPI0414541A (pt) | compostos heterocìclicos fundidos | |
BRPI0410711A (pt) | novos compostos | |
BR0313676A (pt) | Derivados de pirimidina e uso destes como moduladores cb2 | |
BR0307833A (pt) | Sìntese controlada de ziprasidona e suas composições | |
BRPI0417543A (pt) | quinolinas úteis no tratamento de doença cardiovascular | |
BRPI0414598A (pt) | indóis substituìdos | |
BRPI0411897A (pt) | pirroldihidroisoquinolinas como inibidores de pde10 | |
BR0113286A (pt) | Pirazóis substituìdos | |
BR0305258A (pt) | Inibidores de polimerase de ns5b de hcv | |
BRPI0413973A (pt) | compostos | |
TW200509892A (en) | Novel aminobenzophenone compounds | |
RS50578B (sr) | Supstituisani 2-aminotetralini za preventivni tretman parkinsonove bolesti | |
CR8009A (es) | Compuestos benzo[1,2,5] tiadiazoles | |
HK1068274A1 (en) | Use of 1-phenyl-3-dimethylaminopropane compounds for treating urinary incontinence | |
BRPI0407913A (pt) | antagonistas receptores de ccr-3 | |
BRPI0412843A (pt) | lactamas substituìdas e uso das mesmas como agentes anticáncer | |
BRPI0413820A (pt) | derivados de 6-cicloamino-2-quinolinona como compostos moduladores de receptor de androgênio | |
BR0312863A (pt) | Derivados de aldeìdo de polietileno glicol | |
MXPA04005079A (es) | Variantes del dominio c2 del factor viii. | |
BR9713176A (pt) | Benzotiofenos amorfos,métodos de preparação e métodos de uso | |
BR9807312A (pt) | Derivados de (4-piperidinil)-1h-2-benzopirano úteis como agentes antipsicóticos | |
BR0317249A (pt) | Método de preparar compostos de aminocianopiridina tricìclica | |
NO20053562L (no) | Nye aminobenzofenonforbindelser |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A E 8A ANUIDADE(S). |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: NAO APRESENTADA A GUIA DE CUMPRIMENTO DE EXIGENCIA. REFERENTE AS 7A E 8A ANUIDADES. |